Suchergebnisse - "BNT162 vaccine"

PubPharm (3.928)

21

Calculate incidence rates of BNT162b2-related arterial or venous thrombosis only from the entire cohort of interest

enthalten in: Thrombosis research | 2024

von Finsterer, J.

22

Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis : analysis of a prospective cohort

enthalten in: Clinical and experimental rheumatology | 2024

von Bartoletti, A. | Fornara, C. | Delvino, P. | +5

23

Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection

enthalten in: Scientific reports | 2024

von Ferrari, L. | Ruggiero, A. | Stefani, C. | +25

24

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine : a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2024

von Oda, Y. | Kumagai, Y. | Kanai, M. | +8

25

Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease : A Prospective, Comparative Study

enthalten in: Inflammatory bowel diseases | 2024

von Mujukian, A. | Kumar, R. | Li, D. | +57

26

Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco

enthalten in: Scientific reports | 2024

von Ezzikouri, S. | Tajudeen, R. | Majidi, H. | +16

27

COVID-19 vaccines and adverse events of special interest : A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

enthalten in: Vaccine | 2024

von Faksova, K. | Walsh, D. | Jiang, Y. | +32

28

Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong

enthalten in: Vaccine | 2024

von Chen, D. | Cowling, B. | Ainslie, K. | +5

29

Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023

enthalten in: Vaccine | 2024

von Moro, P. | Carlock, G. | Fifadara, N. | +4

30

Mesoscopic Structure of Lipid Nanoparticle Formulations for mRNA Drug Delivery : Comirnaty and Drug-Free Dispersions

enthalten in: ACS nano | 2024

von Unruh, T. | Götz, K. | Vogel, C. | +4